Skip to main content
Displaying 1 - 12 of 12
Display:
12
24
48
Viral Hepatitis
1
GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session) - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
1
GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session) - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
1
GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session) - EASL Congress 2024
View
Viral Hepatitis
1
GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session) - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
3
Novo Nordisk: Navigating MASH patient care - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
3
Novo Nordisk: Navigating MASH patient care - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
3
Novo Nordisk: Navigating MASH patient care - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
5
Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes - EASL Congress 2024
View
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy